About Dr. Lalit Kumar
Padma Shri Awardee, Dr. Lalit Kumar is a highly respected and leading oncologist in India, renowned for his visionary contributions to medical oncology and stem cell transplantation. With over 35 years of extensive experience, he has made significant advancements in treating haematological and gynaecological cancers. Dr. Kumar is particularly recognised for pioneering cost-effective treatment protocols for bone marrow and stem cell transplants, making advanced cancer care more accessible. He has also served as Professor and Head (Medical Oncology) at AIIMS, New Delhi for several years. His commitment to innovative cancer treatment continues to profoundly impact patient outcomes both nationally and internationally. He is renowned to have developed most affordable treatment protocols for stem cell transplantations and sustained bone marrow.He is undoubtedly one of the top medical oncologists in India.
Qualifications & Credentials
- MBBS – Sarojini Naidu Medical College, Agra
- MD (Medicine) – Sarojini Naidu Medical College, Agra
- DM Medical Oncology – Adyar Cancer Institute, Chennai
- Post-Doctoral Fellowship – Royal Postgraduate Medical School of the Hammersmith Hospital, London
- Fulbright Scholarship – United States of America
- Advanced training in bone marrow transplantation and stem cell therapy
- Fellowship: Indian Academy of Sciences (FASc)
- Fellowship: National Academy of Medical Sciences of India (FAMS)
- Fellowship: National Academy of Sciences (FNASI)
- Member of Expert Committee to examine the Serious Adverse Events (SAE) of deaths occurring during clinical trials
- Indo British Health Initiative (IBHI)
- Institute of Women's Health, University College London (IFWH, UCL)
Areas of Expertise
- Acute Lymphoblastic Leukaemia
- Acute Myeloid Leukaemia
- Blood Cancer
- Chronic Myeloid Leukaemia
- Chronic Lymphocytic Leukaemia
- Hairy Cell Leukaemia
- Chronic Myelomonocytic Leukaemia
- Hodgkin Lymphoma
- Leukaemia
- Myelodysplastic Syndromes
- Non-Hodgkin Lymphoma
- Cervical Cancer
- Ovarian Cancer
- Germ Cell Ovarian Cancer
- Multiple Myeloma
- Various blood cancers and solid tumours
- Medical Oncology
- Haemato-Oncology
- Bone Marrow Transplantation (BMT) / Stem Cell Therapy
- Gynaecological Oncology
- Infection Management in Cancer Patients
- Bone Marrow Transplantation (BMT)
- Stem Cell Therapy
- Neoadjuvant Chemotherapy Protocols
- Targeted Therapy Implementation
- Complex Chemotherapy Protocols
- Infection Management in Immunocompromised Patients
List of Disease and Treatment for which Dr. Lalit Kumar can be consulted
Professional Experience
- Chairperson – Oncology & BMT, Artemis Hospitals, Gurugram
- Former Professor and Head in the Department of Medical Oncology at AIIMS, New Delhi.
- Extensive involvement in medical education and training.
- Leadership in clinical research and protocol development.
- Pioneered cost-effective protocols for bone marrow and stem cell transplants.
- Developed cost-effective treatment protocols for sustained bone marrow and stem cell transplantations.
- Visionary contributions to medical oncology in India.
- International recognition for oncology and BMT expertise.
Awards & Recognitions
- Padma Shri Award (2014) – One of India's highest civilian honours
- Dr. B.C. Roy Award (2008) – The premier medical award in India
- Indian Council of Medical Research (ICMR) Award
- Ranbaxy Science Foundation Award
- Fellow of Indian Academy of Sciences (FASc)
- Fellow of National Academy of Medical Sciences of India (FAMS)
- Fellow of National Academy of Sciences (FNASI)
Research & Publications
- Respiratory Syncytial Virus Infection among Adults after Hematopoietic Stem Cell Transplantation (Aug 2022)
- Monoclonal Gammopathy of Renal Significance: Histomorphological Spectrum at a Tertiary Care Center (Aug 2022)
- Application of Bio-Active Elastin-like Polypeptide on Regulation of Human Mesenchymal Stem Cell Behavior (May 2022)
- Human metapneumovirus infection in haematopoietic stem cell transplant recipients: a case series (Mar 2021)
- Incidence of Respiratory Syncytial Virus Infection among Adults Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Study from India (Oct 2019)
- Challenges to Effective CC (Apr 2014)
- The Lancet Oncology Commission Challenges to effective cancer control in China, India, and Russia (Apr 2014)
- Challenges to effective cancer control in China, India, and Russia (Apr 2014)
- Extensive research in haematological malignancies and gynaecological cancers.
- Development of innovative treatment protocols.
- International collaborations in oncology research.
- Continuous advancement in BMT and stem cell therapy techniques.
Patient Success Stories & Testimonials
Treatment Approach & Philosophy
Treatment Costs
Treatment Type | Estimated Cost in INR | Estimated Cost in USD |
Bone Marrow Transplant (BMT) | ₹15,00,000 - ₹30,00,000 | $18,000 - $36,000 |
Chemotherapy Cycle | ₹50,000 - ₹2,00,000 | $600 - $2,400 |
Targeted Therapy (per session/cycle) | ₹1,00,000 - ₹5,00,000 | $1,200 - $6,000 |
Ovarian Cancer Treatment | ₹5,00,000 - ₹15,00,000 | $6,000 - $18,000 |
Blood Cancer Treatment | ₹8,00,000 - ₹25,00,000 | $9,600 - $30,000 |